Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-11-18 Sale | 2025-11-20 5:21 pm | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 1,127 | $9.27 | $10,447 | 240,991 (Direct) | View |
| 2025-11-18 Sale | 2025-11-20 5:20 pm | Lexeo Therapeutics Inc. | LXEO | Adler Eric Chief Medical Officer | 615 | $9.27 | $5,701 | 72,646 (Direct) | View |
| 2025-11-18 Sale | 2025-11-20 5:19 pm | Lexeo Therapeutics Inc. | LXEO | See Tai Sandi Chief Development Officer | 386 | $9.27 | $3,578 | 65,476 (Direct) | View |
| 2025-11-18 Sale | 2025-11-20 5:18 pm | Lexeo Therapeutics Inc. | LXEO | Robertson Jenny Chief Legal Officer | 549 | $9.27 | $5,089 | 68,381 (Direct) | View |
| 2025-08-18 Sale | 2025-11-20 5:14 pm | Lexeo Therapeutics Inc. | LXEO | Otero Jose Manuel Chief Technical Officer | 721 | $9.27 | $6,684 | 63,476 (Direct) | View |
| 2025-10-17 Sale | 2025-10-17 7:29 pm | Lexeo Therapeutics Inc. | LXEO | See Tai Sandi Chief Development Officer | 3,888 | $8.9421 | $34,767 | 65,862 (Direct) | View |
| 2025-10-17 Sale | 2025-10-17 7:28 pm | Lexeo Therapeutics Inc. | LXEO | Robertson Jenny Chief Legal Officer | 3,526 | $8.9421 | $31,530 | 68,930 (Direct) | View |
| 2025-10-17 Sale | 2025-10-17 7:28 pm | Lexeo Therapeutics Inc. | LXEO | Otero Jose Manuel Chief Technical Officer | 2,115 | $8.9421 | $18,913 | 64,197 (Direct) | View |
| 2025-10-17 Sale | 2025-10-17 7:26 pm | Lexeo Therapeutics Inc. | LXEO | Adler Eric Chief Medical Officer | 3,382 | $8.942 | $30,242 | 73,261 (Direct) | View |
| 2025-10-17 Sale | 2025-10-17 7:26 pm | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 13,133 | $8.9421 | $117,436 | 242,118 (Direct) | View |
| 2025-08-18 Sale(A) | 2025-09-10 4:59 pm | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 1,115 | $4.668 | $5,205 | 220,058 (Direct) | View |
| 2025-08-18 Sale | 2025-08-20 5:05 pm | Lexeo Therapeutics Inc. | LXEO | Otero Jose Manuel Chief Technical Officer | 2,848 | $4.668 | $13,294 | 60,372 (Direct) | View |
| 2025-08-18 Sale | 2025-08-20 5:03 pm | Lexeo Therapeutics Inc. | LXEO | Robertson Jenny Chief Legal Officer | 542 | $4.668 | $2,530 | 62,556 (Direct) | View |
| 2025-08-18 Sale | 2025-08-20 5:02 pm | Lexeo Therapeutics Inc. | LXEO | Adler Eric Chief Medical Officer | 608 | $4.668 | $2,838 | 67,073 (Direct) | View |
| 2025-08-18 Sale | 2025-08-20 5:00 pm | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 2,735 | $4.668 | $12,767 | 220,058 (Direct) | View |
| 2025-08-18 Sale | 2025-08-20 4:58 pm | Lexeo Therapeutics Inc. | LXEO | See Tai Sandi Chief Development Officer | 382 | $4.668 | $1,783 | 58,860 (Direct) | View |
| 2025-05-16 Sale | 2025-05-20 5:00 pm | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 1,074 | $2.774 | $2,979 | 221,173 (Direct) | View |
| 2025-05-16 Sale | 2025-05-20 5:00 pm | Lexeo Therapeutics Inc. | LXEO | Adler Eric Chief Medical Officer | 585 | $2.774 | $1,623 | 67,681 (Direct) | View |
| 2025-05-16 Sale | 2025-05-20 5:00 pm | Lexeo Therapeutics Inc. | LXEO | Robertson Jenny Chief Legal Officer | 521 | $2.774 | $1,445 | 63,098 (Direct) | View |
| 2025-05-16 Sale | 2025-05-20 5:00 pm | Lexeo Therapeutics Inc. | LXEO | See Tai Sandi Chief Development Officer | 367 | $2.774 | $1,018 | 59,242 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 5:10 pm | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 4,326 | $4.413 | $19,091 | 220,119 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 5:09 pm | Lexeo Therapeutics Inc. | LXEO | See Tai Sandi Chief Development Officer | 1,486 | $4.413 | $6,558 | 53,889 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 5:09 pm | Lexeo Therapeutics Inc. | LXEO | Adler Eric Chief Medical Officer | 2,359 | $4.413 | $10,410 | 68,266 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 5:08 pm | Lexeo Therapeutics Inc. | LXEO | Robertson Jenny Chief Legal Officer | 2,101 | $4.413 | $9,272 | 57,899 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-10-15 Option Award | 2025-10-17 7:29 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | See Tai Sandi Chief Development Officer | 10,890 | $0 | 65,862 (Direct) | View |
| 2025-10-15 Option Award | 2025-10-17 7:28 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Robertson Jenny Chief Legal Officer | 9,900 | $0 | 68,930 (Direct) | View |
| 2025-10-15 Option Award | 2025-10-17 7:28 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Otero Jose Manuel Chief Technical Officer | 5,940 | $0 | 64,197 (Direct) | View |
| 2025-10-15 Option Award | 2025-10-17 7:26 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Adler Eric Chief Medical Officer | 9,570 | $0 | 73,261 (Direct) | View |
| 2025-10-15 Option Award | 2025-10-17 7:26 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 33,000 | $0 | 242,118 (Direct) | View |
| 2025-09-12 Option Award | 2025-09-16 5:30 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 2,193 | $2.644 | 222,251 (Direct) | View |
| 2025-08-29 Option Award | 2025-09-03 2:00 pm | N/A 2035-08-28 | Lexeo Therapeutics Inc. | LXEO | Tamayo Louis Edward Chief Financial Officer | 325,000 | $0 | 325,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-30 5:00 pm | N/A 2035-06-25 | Lexeo Therapeutics Inc. | LXEO | Tanguler Tolga Director | 14,583 | $0 | 14,583 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-30 5:00 pm | N/A 2035-06-25 | Lexeo Therapeutics Inc. | LXEO | Van Hauwermeiren Timothy Director | 22,916 | $0 | 22,916 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-30 5:00 pm | N/A 2035-06-25 | Lexeo Therapeutics Inc. | LXEO | DIAZ REINALDO M Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-30 5:00 pm | N/A 2035-06-25 | Lexeo Therapeutics Inc. | LXEO | COOPERSTONE BRENDA Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-30 5:00 pm | N/A 2035-06-25 | Lexeo Therapeutics Inc. | LXEO | CHOLMONDELEY PAULA H Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-30 5:00 pm | N/A 2035-06-25 | Lexeo Therapeutics Inc. | LXEO | Altschuler Steven Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-30 5:00 pm | N/A 2035-06-25 | Lexeo Therapeutics Inc. | LXEO | Agger Mette Kirstine Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-03-14 Option Award | 2025-04-09 5:48 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Otero Jose Manuel Chief Technical Officer | 5,720 | $2.61 | 63,220 (Direct) | View |
| 2025-03-14 Option Award | 2025-04-09 5:46 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Robertson Jenny Chief Legal Officer | 5,720 | $2.61 | 63,619 (Direct) | View |
| 2025-03-14 Option Award | 2025-04-09 5:44 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | See Tai Sandi Chief Development Officer | 5,720 | $2.61 | 59,609 (Direct) | View |
| 2025-03-14 Option Award | 2025-04-01 7:58 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 2,128 | $2.61 | 222,247 (Direct) | View |
| 2025-01-17 Option Award | 2025-01-22 4:55 pm | N/A 2035-01-16 | Lexeo Therapeutics Inc. | LXEO | Rasbach Kyle Chief Financial Officer | 286,125 | $0 | 286,125 (Direct) | View |
| 2025-01-07 Option Award | 2025-01-10 4:55 pm | N/A 2035-01-06 | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 311,250 | $0 | 431,945 (Direct) | View |